Tenaya Therapeutics (TNYA) Short Interest Ratio & Short Volume $0.67 -0.01 (-0.80%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.68 +0.01 (+1.25%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tenaya Therapeutics Short Interest DataTenaya Therapeutics (TNYA) has a short interest of 10.20 million shares, representing 7.60% of the float (the number of shares available for trading by the public). This marks a -4.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.1, indicating that it would take 4.1 days of the average trading volume of 2.36 million shares to cover all short positions.Current Short Interest10,200,000 sharesPrevious Short Interest10,700,000 sharesChange Vs. Previous Month-4.67%Dollar Volume Sold Short$7.04 millionShort Interest Ratio4.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares162,670,000 sharesFloat Size134,180,000 sharesShort Percent of Float7.60%Today's Trading Volume1,574,661 sharesAverage Trading Volume2,358,417 sharesToday's Volume Vs. Average67% Short Selling Tenaya Therapeutics? Sign up to receive the latest short interest report for Tenaya Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTNYA Short Interest Over TimeTNYA Days to Cover Over TimeTNYA Percentage of Float Shorted Over Time Tenaya Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202510,200,000 shares $7.04 million -4.7%7.6%4.1 $0.69 6/30/202510,700,000 shares $6.54 million -10.0%8.0%4.5 $0.61 6/15/202511,890,000 shares $7.03 million -1.3%8.9%4.9 $0.59 5/31/202512,050,000 shares $5.45 million -0.9%9.0%3.9 $0.45 5/15/202512,160,000 shares $5.32 million +39.3%9.1%3.5 $0.44 4/30/20258,730,000 shares $4.15 million -0.5%6.5%2.6 $0.48 4/15/20258,770,000 shares $4.45 million -19.0%6.5%2.7 $0.51 3/31/202510,820,000 shares $6.17 million -3.6%8.1%3.2 $0.57 3/15/202511,220,000 shares $7.84 million -22.1%8.4%3 $0.70 2/28/202514,400,000 shares $14.54 million +7.7%11.3%3.4 $1.01 Get the Latest News and Ratings for TNYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tenaya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202513,370,000 shares $16.04 million +9.2%20.5%3.4 $1.20 1/31/202512,240,000 shares $12.97 million +6.6%18.7%2.8 $1.06 1/15/202511,480,000 shares $16.88 million -7.6%17.5%2.4 $1.47 12/31/202412,420,000 shares $17.76 million -25.6%18.9%2.6 $1.43 12/15/202416,690,000 shares $45.90 million +18.8%25.4%3.8 $2.75 11/30/202414,050,000 shares $50.16 million +7.1%21.4%4.8 $3.57 11/15/202413,120,000 shares $25.85 million +150.4%20.0%5.7 $1.97 10/31/20245,240,000 shares $10.06 million +7.4%8.0%3.4 $1.92 10/15/20244,880,000 shares $8.25 million -3.9%7.5%10.6 $1.69 9/30/20245,080,000 shares $9.80 million -2.7%7.8%12.9 $1.93 9/15/20245,220,000 shares $10.44 million +11.1%8.0%12.6 $2.00 8/31/20244,700,000 shares $12.60 million +1.5%7.2%12.4 $2.68 8/15/20244,630,000 shares $13.89 million +4.5%7.1%12.4 $3.00 7/31/20244,430,000 shares $15.51 million +0.9%6.8%12 $3.50 7/15/20244,390,000 shares $15.45 million +12.9%6.7%12.4 $3.52 6/30/20243,890,000 shares $12.06 million +15.1%6.0%11 $3.10 6/15/20243,380,000 shares $11.36 million -1.7%5.2%11.1 $3.36 5/31/20243,440,000 shares $14.48 million +2.7%5.3%9.1 $4.21 5/15/20243,350,000 shares $14.24 million -7.7%5.1%7.8 $4.25 4/30/20243,630,000 shares $16.48 million +7.7%5.8%7.2 $4.54 4/15/20243,370,000 shares $15.06 million +9.1%5.4%6.2 $4.47 3/31/20243,090,000 shares $16.16 million +21.2%5.0%5.1 $5.23 3/15/20242,550,000 shares $12.69 million -10.2%4.1%4.1 $4.98 2/29/20242,840,000 shares $16.90 million +14.5%4.7%5 $5.95 2/15/20242,480,000 shares $14.33 million -7.5%4.1%4.7 $5.78 1/31/20242,680,000 shares $11.27 million +14.0%6.0%5.9 $4.21 1/15/20242,350,000 shares $7.19 million -0.8%5.2%5.6 $3.06 12/31/20232,370,000 shares $7.68 million +19.7%5.3%6.8 $3.24 12/15/20231,980,000 shares $4.12 million -23.6%4.4%5.4 $2.08 11/30/20232,590,000 shares $4.87 million +5.3%5.8%6.9 $1.88Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 11/15/20232,460,000 shares $4.48 million -16.6%5.5%7.2 $1.82 10/31/20232,950,000 shares $5.37 million -2.0%6.6%8.6 $1.82 10/15/20233,010,000 shares $6.89 million -8.8%6.7%8.6 $2.29 9/30/20233,300,000 shares $8.42 million +3.1%7.4%9.4 $2.55 9/15/20233,200,000 shares $10.27 million +9.6%7.1%9.7 $3.21 8/31/20232,920,000 shares $11.30 million +3.6%6.6%9 $3.87 8/15/20232,820,000 shares $11.03 million +11.9%6.3%7.3 $3.91 7/31/20232,520,000 shares $12.20 million -23.9%6.2%5.2 $4.84 7/15/20233,310,000 shares $18.17 million +5.4%8.1%5 $5.49 6/30/20233,140,000 shares $18.43 million +6.4%7.7%4.6 $5.87 6/15/20232,950,000 shares $19.77 million +20.4%7.2%4.5 $6.70 5/31/20232,450,000 shares $17.64 million +18.9%6.0%3.7 $7.20 5/15/20232,060,000 shares $14.42 million +30.4%5.0%3.2 $7.00 4/30/20231,580,000 shares $8.40 million -6.5%3.9%2.6 $5.32 4/15/20231,690,000 shares $4.85 million +1.8%4.1%3.6 $2.87 3/31/20231,660,000 shares $4.73 million +84.6%4.2%4.7 $2.85 3/15/2023899,400 shares $2.36 million +14.9%2.3%2.5 $2.63 2/28/2023782,600 shares $2.40 million -10.3%2.1%2.7 $3.07 2/15/2023872,200 shares $2.67 million +3.9%2.3%2.7 $3.06 1/31/2023839,400 shares $2.87 million -2.4%2.1%2.3 $3.42 1/15/2023859,600 shares $1.97 million +2.4%2.2%2.8 $2.29 12/30/2022839,300 shares $1.69 million -15.2%2.1%3.1 $2.01 12/15/2022990,000 shares $2.35 million -14.7%2.0%3.6 $2.37 11/30/20221,160,000 shares $3.07 million -10.1%2.7%4.4 $2.65 11/15/20221,290,000 shares $3.78 million -0.8%3.1%5.6 $2.93 10/31/20221,300,000 shares $3.48 million -13.3%4.6%8.2 $2.68 10/15/20221,500,000 shares $3.69 million -1.3%5.3%9.3 $2.46 9/30/20221,520,000 shares $4.41 million No Change5.4%8.8 $2.90 9/15/20221,520,000 shares $6.10 million -6.2%5.4%8.4 $4.01 8/31/20221,620,000 shares $7.11 million -10.0%5.7%9.6 $4.39 8/15/20221,800,000 shares $10.31 million -26.8%6.4%10.9 $5.73 7/31/20222,460,000 shares $11.73 million No Change8.7%16.8 $4.77 7/15/20222,460,000 shares $12.79 million -39.0%8.7%19 $5.20 6/30/20224,030,000 shares $22.69 million +7.2%14.3%34.8 $5.63 6/15/20223,760,000 shares $20.45 million +1.6%13.3%34.6 $5.44 5/31/20223,700,000 shares $24.79 million -1.1%13.1%27.8 $6.70 5/15/20223,740,000 shares $26.55 million -0.5%13.3%25.4 $7.10 4/30/20223,760,000 shares $34.67 million +1.1%13.3%24.4 $9.22 4/15/20223,720,000 shares $42.56 million +1.6%13.2%22.7 $11.44 3/31/20223,660,000 shares $43.11 million +13.3%13.0%19.9 $11.78 3/15/20223,230,000 shares $37.08 million +10.6%11.4%17 $11.48 2/28/20222,920,000 shares $34.05 million +4.3%10.3%18.2 $11.66 2/15/20222,800,000 shares $42.53 million +4.9%9.9%18.4 $15.19 1/31/20222,670,000 shares $31.83 million +6.8%10.2%18.4 $11.92 1/15/20222,500,000 shares $25 million +25.6%9.5%19.2 $10.00 12/31/20211,990,000 shares $37.71 million No Change7.6%16.8 $18.95 TNYA Short Interest - Frequently Asked Questions What is Tenaya Therapeutics' current short interest? Short interest is the volume of Tenaya Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 10,200,000 shares of TNYA short. 7.60% of Tenaya Therapeutics' shares are currently sold short. Learn More on Tenaya Therapeutics' current short interest. What is a good short interest ratio for Tenaya Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNYA shares currently have a short interest ratio of 4.0. Learn More on Tenaya Therapeutics's short interest ratio. Which institutional investors are shorting Tenaya Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tenaya Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Tenaya Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.60% of Tenaya Therapeutics' floating shares are currently sold short. Is Tenaya Therapeutics' short interest increasing or decreasing? Tenaya Therapeutics saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 10,200,000 shares, a decline of 4.7% from the previous total of 10,700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tenaya Therapeutics' float size? Tenaya Therapeutics currently has issued a total of 162,670,000 shares. Some of Tenaya Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenaya Therapeutics currently has a public float of 134,180,000 shares. How does Tenaya Therapeutics' short interest compare to its competitors? 7.60% of Tenaya Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tenaya Therapeutics: Arvinas, Inc. (10.71%), Phathom Pharmaceuticals, Inc. (13.88%), Taysha Gene Therapies, Inc. (20.48%), Valneva SE Sponsored ADR (0.03%), Precigen, Inc. (19.44%), Rapport Therapeutics, Inc. (16.39%), Opthea Limited Unsponsored ADR (0.36%), aTyr Pharma, Inc. (23.68%), Solid Biosciences Inc. (18.18%), Terns Pharmaceuticals, Inc. (9.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Tenaya Therapeutics stock? Short selling TNYA is an investing strategy that aims to generate trading profit from Tenaya Therapeutics as its price is falling. TNYA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tenaya Therapeutics? A short squeeze for Tenaya Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNYA, which in turn drives the price of the stock up even further. How often is Tenaya Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNYA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Arvinas Short Interest Data Phathom Pharmaceuticals Short Interest Data Taysha Gene Therapies Short Interest Data Valneva Short Interest Data Precigen Short Interest Data Rapport Therapeutics Short Interest Data Opthea Short Interest Data aTyr Pharma Short Interest Data Solid Biosciences Short Interest Data Terns Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNYA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
